31,724 Shares in Kenvue Inc. $KVUE Purchased by Index Fund Advisors Inc.

Index Fund Advisors Inc. acquired a new position in Kenvue Inc. (NYSE:KVUE) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 31,724 shares of the company’s stock, valued at approximately $515,000.

Other hedge funds also recently bought and sold shares of the company. AlphaCore Capital LLC raised its stake in shares of Kenvue by 9.9% during the second quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares in the last quarter. Empirical Finance LLC boosted its stake in shares of Kenvue by 1.8% during the second quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock valued at $593,000 after purchasing an additional 491 shares in the last quarter. Proffitt & Goodson Inc. lifted its position in shares of Kenvue by 8.2% during the second quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock valued at $143,000 after buying an additional 517 shares during the last quarter. UMB Bank n.a. raised its stake in Kenvue by 22.3% in the second quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock valued at $60,000 after buying an additional 521 shares during the last quarter. Finally, Altus Wealth Group LLC raised its position in Kenvue by 1.7% during the 2nd quarter. Altus Wealth Group LLC now owns 31,398 shares of the company’s stock worth $657,000 after buying an additional 524 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on KVUE shares. Evercore ISI set a $18.00 price objective on shares of Kenvue in a research note on Tuesday, October 28th. Canaccord Genuity Group reissued a “hold” rating and issued a $15.00 price target (down from $26.00) on shares of Kenvue in a research note on Wednesday, October 29th. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft set a $18.00 price objective on shares of Kenvue in a report on Friday, October 24th. Finally, Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $20.23.

Kenvue Stock Down 0.5%

KVUE stock opened at $16.74 on Wednesday. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The company has a fifty day moving average of $16.74 and a 200-day moving average of $18.48. The stock has a market capitalization of $32.07 billion, a PE ratio of 22.32 and a beta of 0.60.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The company had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.83 billion. During the same period last year, the firm earned $0.28 EPS. The company’s revenue for the quarter was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Investors of record on Wednesday, November 12th were given a $0.2075 dividend. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 annualized dividend and a dividend yield of 5.0%. Kenvue’s payout ratio is currently 110.67%.

Insiders Place Their Bets

In other news, Director Jeffrey C. Smith acquired 3,200,000 shares of Kenvue stock in a transaction that occurred on Friday, December 12th. The shares were acquired at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the purchase, the director owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This represents a 13.27% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.17% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.